CCND1 and hepatocellular carcinoma: Lycopene supplementation (2.2 mg/kg/6.6 mg/kg) aided in managing steatohepatitis and HCC by attenuating body weight, liver weight, hepatic lesions, cyclin D1 levels, NF‐kB, and MMP‐2.